NeuroSense Therapeutics
attenuated slow vital capacity by | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
December 2023
Slide
21 of 33
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
January 2024
slow vital capacity observed a decrease in patients treated with placebo | NeuroSense Therapeutics
Investor Presentation
January 2024
attenuated disease progression by difference in | NeuroSense Therapeutics
Investor Presentation
January 2024
attenuated slow vital capacity by wass | NeuroSense Therapeutics
Investor Presentation
January 2024
significantly attenuated disease progression by in phase study results per protocol population analysis | NeuroSense Therapeutics
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
October 2024
Investor Presentation
January 2024
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights